Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19792926804external-prioritypatent/DE2926804A1/en
Priority claimed from DE19803013930external-prioritypatent/DE3013930A1/en
Application filed by Dr. Karl Thomae GmbhfiledCriticalDr. Karl Thomae Gmbh
Priority claimed from EP80103408Aexternal-prioritypatent/EP0023559B1/en
Application grantedgrantedCritical
Publication of ATE9471T1publicationCriticalpatent/ATE9471T1/en
AT80103408T1979-07-031980-06-19
2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO(5,4D)PYRIMIDINE, THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
ATE9471T1
(en)
2-Per:hydro-1,4-di:azino-pyrimido-(5,4-D)-pyrimidine derivs. - have antithrombotic, phosphodiesterase inhibiting, and cancer cell aggregation inhibiting activities
3-(3'-AMINO-2'-HYDROXY-N-PROP-1'-OXY)-6ISOPROPYLIDENEHYDRAZINOPYRIDAZINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.